Blue Goat Cyber logoBlue Goat CyberSMMedical Device Cybersecurity
    K
    Hero illustration for the article: STRIDE Threat Modeling for Medical Devices
    Guide · Threat Modeling

    STRIDE Threat Modeling for Medical Devices

    Master STRIDE threat modeling for medical devices. Learn to identify risks, meet FDA premarket requirements, and secure your MedTech ecosystem. Read our guide.

    Hero illustration for the article: STRIDE Threat Modeling for Medical Devices
    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA, CISSP

    Founder & CEO · Blue Goat Cyber

    Master STRIDE threat modeling for medical devices. Learn to identify risks, meet FDA premarket requirements, and secure your MedTech ecosystem. Read our guide.

    This guide is written for medical device manufacturers navigating STRIDE threat modeling medical devices. It is built from real submissions, FDA correspondence, and the standards reviewers actually cite. Use it as a working reference: read straight through, jump to the section that matches your current gap, or hand it to your engineering and regulatory leads as a checklist.

    Introduction to STRIDE in the Medical Device Context

    Introduction to STRIDE in the Medical Device Context is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Why Threat Modeling is Critical for FDA Premarket Submissions

    Why Threat Modeling is Critical for FDA Premarket Submissions — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    How STRIDE Fits into the Secure Product Development Framework (SPDF)

    How STRIDE Fits into the Secure Product Development Framework (SPDF) — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Breaking Down the STRIDE Categories for MedTech

    Breaking Down the STRIDE Categories for MedTech is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Spoofing: Identity Risks in Connected Devices

    Spoofing: Identity Risks in Connected Devices — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Tampering: Maintaining Data Integrity for Patient Safety

    Tampering: Maintaining Data Integrity for Patient Safety — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Repudiation: Audit Trails and Accountability

    Repudiation: Audit Trails and Accountability — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Information Disclosure: Protecting PHI and Proprietary Data

    Information Disclosure: Protecting PHI and Proprietary Data — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Denial of Service: Ensuring Availability of Life-Critical Functions

    Denial of Service: Ensuring Availability of Life-Critical Functions — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Elevation of Privilege: Controlling Access in Hospital Environments

    Elevation of Privilege: Controlling Access in Hospital Environments — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    The 4-Step Medical Device Threat Modeling Process

    The 4-Step Medical Device Threat Modeling Process is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Step 1: Decomposing the System (Data Flow Diagrams)

    Step 1: Decomposing the System (Data Flow Diagrams) — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Step 2: Applying the STRIDE Mnemonic to Components

    Step 2: Applying the STRIDE Mnemonic to Components — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Step 3: Risk Assessment and Mitigation Strategies

    Step 3: Risk Assessment and Mitigation Strategies — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Step 4: Validation and Traceability for Regulatory Audits

    Step 4: Validation and Traceability for Regulatory Audits — make sure your design history file documents the rationale, the standard you mapped to, and the objective evidence that closes the loop. Reviewers expect to trace the requirement, the test, and the residual risk in a single thread.

    Common STRIDE Pitfalls in MedTech Submissions

    Common STRIDE Pitfalls in MedTech Submissions is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Integrating STRIDE with AAMI TIR57 and ISO 14971

    Integrating STRIDE with AAMI TIR57 and ISO 14971 is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Conclusion: From Threat Model to Secure Architecture

    Conclusion: From Threat Model to Secure Architecture is one of the areas FDA reviewers probe hardest in modern submissions. The points below summarize what we ship in client packages and what we have seen FDA accept and reject across 250+ device submissions.

    Frequently asked questions

    Is STRIDE required by the FDA for medical device submissions?

    Short answer: It depends on the device classification, intended use, and connectivity profile — but the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

    How do you create a Data Flow Diagram (DFD) for a medical device?

    Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

    What is the difference between STRIDE and PASTA for MedTech?

    Short answer: STRIDE threat modeling medical devices is a discrete deliverable inside the Secure Product Development Framework (SPDF). FDA expects it documented, traceable, and version-controlled inside your QMS. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

    How does threat modeling relate to medical device risk management (ISO 14971)?

    Short answer: Treat it as a process, not a one-off document: own the requirement in design controls, map it to a current standard, generate evidence during V&V, and surface the residual risk in your postmarket plan. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

    What level of detail does the FDA expect in a threat model?

    Short answer: It depends on the device classification, intended use, and connectivity profile — but the controlling references are FDA's February 2026 premarket guidance, AAMI SW96, and IEC 81001-5-1. The sections above walk through how each applies. For the full context, work through the relevant section above and the linked services below — every answer here is grounded in current FDA guidance and the standards your reviewer is using.

    Where this fits in the cluster

    This page sits downstream of our pillar resources on STRIDE threat modeling medical devices. If you arrived here from a different starting point, these are the most useful adjacent pages:

    Sources & primary references

    Talk to a regulatory cybersecurity team

    If you are working through STRIDE threat modeling medical devices and want a second pair of eyes on your submission package, we ship cybersecurity deliverables for medical device manufacturers across 510(k), De Novo, PMA, and EU MDR pathways. Book a discovery session and we will walk your evidence with you.

    Sources & references

    Primary sources cited in this article. Links open in a new tab.

    1. Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions- U.S. FDA
    2. NIST SP 800-154: Guide to Data-Centric System Threat Modeling- NIST
    3. Principles and Practices for Medical Device Cybersecurity- IMDRF
    Related - Threat Modeling

    Continue exploring this topic

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.